Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 204S204 trades$51.20M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Saldanha CraigChief Product Officer |  YELPYELP INCOpen-market sale · 10b5-1 plan | SELL | $33K 1,200 sh | Feb 4, 2026 |
| 5 | Vultaggio VincentPAO and PFO |  ZNTLZentalis Pharmaceuticals, Inc.Open-market sale · 10b5-1 plan | SELL | $6,477 2,540 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 3 | Remer Eric RichardDirector, Chief Executive Officer |  EVCMEverCommerce Inc.Open-market sale · 10b5-1 plan | SELL | $20K 1,700 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 3 | Remer Eric RichardDirector, Chief Executive Officer | EVCMEverCommerce Inc. Open-market sale · 10b5-1 plan | SELL | $30K 2,797 sh | Feb 4, 2026 traded Feb 4, 2026 |
| 1 | Barrett David MichaelDirector, Chief Executive Officer |  EXFYExpensify, Inc.Open-market sale · 10b5-1 plan | SELL | $44K 30.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 1 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $75K 381 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 1 | Sieffert Kristen NPresident |  FOAFinance of America Companies Inc.Open-market sale · 10b5-1 plan | SELL | $17K 750 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 1 | Vultaggio VincentPAO and PFO | ZNTLZentalis Pharmaceuticals, Inc. Open-market sale · 10b5-1 plan | SELL | $1,398 556 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 0 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $7,449 39 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $4,499 23 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $192 1 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $4,535 23 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 37 | Running Michael J.Regional President - AMER |  PLXSPLEXUS CORPOpen-market sale | SELL | $190K 926 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 33 | Dechairo BryanChief Operating Officer |  WGSGeneDx Holdings Corp.Open-market sale | SELL | $165K 1,662 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 33 | Dechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Open-market sale | SELL | $117K 1,166 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 30 | Dechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Open-market sale | SELL | $49K 492 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 29 | Lee David EricVICE CHAIR, WINTRUST FINANCIAL |  WTFCWINTRUST FINANCIAL CORPOpen-market sale | SELL | $82K 558 sh | Feb 3, 2026 traded Jan 30, 2026 |
| 26 | Dechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Open-market sale | SELL | $8,999 93 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 19 | Robinson Jill L.EVP, CFO & Treasurer |  BATRKAtlanta Braves Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $800K 20.0K sh | Feb 3, 2026 traded Feb 2, 2026 |
| 10 | Smith Chad M.Pres & COO, Better Mortgage |  BETRBetter Home & Finance Holding CoOpen-market sale · 10b5-1 plan | SELL | $84K 3,097 sh | Feb 3, 2026 traded Feb 3, 2026 |
| 10 | Malcolm JanDirector |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $24K 50 sh | Feb 3, 2026 traded Feb 3, 2026 |
| 9 | Ohlgart ChristianeChief Financial Officer |  FTNTFortinet, Inc.Open-market sale · 10b5-1 plan | SELL | $41K 507 sh | Feb 3, 2026 traded Feb 3, 2026 |
| 6 | Jedrzejek DavidSVP and General Counsel |  LEVILEVI STRAUSS & COOpen-market sale · 10b5-1 plan | SELL | $44K 2,248 sh | Feb 3, 2026 traded Feb 3, 2026 |
| 4 | Badjate PramodPresident & GM, NFB |  NTGRNETGEAR, INC.Open-market sale · 10b5-1 plan | SELL | $63K 3,000 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 1 | Schubach Sarah ElizabethChief Accounting Officer |  DBXDROPBOX, INC.Open-market sale · 10b5-1 plan | SELL | $38K 1,462 sh | Feb 3, 2026 traded Jan 30, 2026 |
| 39 | Donovan James JosephChief Lending Officer/FSVP |  UNTYUNITY BANCORP INC /NJ/Open-market sale | SELL | $14K 265 sh | Feb 2, 2026 traded Jan 29, 2026 |
| 35 | Krohne Susan EChief Legal Officer, Secretary |  MHOM/I HOMES, INC.Open-market sale | SELL | $671K 5,000 sh | Feb 2, 2026 traded Jan 30, 2026 |
| 22 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $126K 2,800 sh | Feb 2, 2026 traded Jan 29, 2026 |
| 22 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $154K 3,500 sh | Feb 2, 2026 traded Jan 29, 2026 |
| 21 |  Thomas RagyDirector |  CXMSprinklr, Inc.Open-market sale | SELL | $6,693 1,054 sh | Feb 2, 2026 traded Jan 29, 2026 |
| 19 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $184 2 sh | Feb 2, 2026 traded Jan 29, 2026 |
| 19 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $30K 315 sh | Feb 2, 2026 traded Jan 29, 2026 |
| 18 | Quartel Adrian WChief Medical Officer |  ZVRAZEVRA THERAPEUTICS, INC.Open-market sale · 10b5-1 plan | SELL | $40K 4,533 sh | Feb 2, 2026 traded Jan 30, 2026 |
| 18 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $52K 1,200 sh | Feb 2, 2026 traded Jan 29, 2026 |
| 14 | Schafer JoshuaCCO | ZVRAZEVRA THERAPEUTICS, INC. Open-market sale · 10b5-1 plan | SELL | $30K 3,375 sh | Feb 2, 2026 traded Jan 30, 2026 |
| 0 | Wren ChrisVP of Operations |  PLNHPlanet 13 Holdings Inc.Open-market sale · 10b5-1 plan | SELL | $4,365 25.0K sh | Feb 2, 2026 traded Jan 30, 2026 |
| 56 | Baker JeffPrincipal Accounting Officer | CRWVCoreWeave, Inc. Open-market sale | SELL | $534K 5,143 sh | Jan 30, 2026 traded Jan 29, 2026 |
| 48 | Sharma VipulChief Technology Officer |  LIFEEthos Technologies Inc.Open-market sale | SELL | $3.57M 200.0K sh | Jan 30, 2026 traded Jan 30, 2026 |
| 48 | Lantz Erin NChief Revenue Officer | LIFEEthos Technologies Inc. Open-market sale | SELL | $2.91M 162.7K sh | Jan 30, 2026 traded Jan 30, 2026 |
| 45 | Terence E. Adderley Revocable Trust K10% Owner |  KELYBKELLY SERVICES INCOpen-market sale | SELL | $106.00M 3.04M sh | Jan 30, 2026 traded Jan 30, 2026 |